Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study-Reference-Cited by-同舟云学术

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Published:2024-06 Issue: Volume:195 Page:110235
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Christ Sebastian M.^ORCID,Alongi Filippo,Ricardi Umberto^ORCID,Scorsetti Marta,Livi Lorenzo,Balermpas Panagiotis^ORCID,Lievens Yolande,Braam Pètra^ORCID,Jereczek-Fossa Barbara Alicja,Stellamans Karin,Ratosa Ivica^ORCID,Widder Joachim^ORCID,Peulen Heike^ORCID,Dirix Piet^ORCID,Bral Samuel,Ramella Sara^ORCID,Hemmatazad Hossein^ORCID,Khanfir Kaouthar^ORCID,Geets Xavier^ORCID,Jeene Paul,Zilli Thomas^ORCID,Fournier Beatrice,Ivaldi Giovanni Battista,Clementel Enrico^ORCID,Fortpied Catherine^ORCID,Oppong Felix Boakye,Ost Piet,Guckenberger Matthias

Funder

Schweizerische Akademie der Medizinischen Wissenschaften

Gottfried und Julia Bangerter-Rhyner-Stiftung

Publisher

Elsevier BV

Reference30 articles.

1. Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document;Lievens;Radiother Oncol,2020

2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Prostate Cancer Version 4.2022 [Internet]. 2022.

3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Non-Small Cell Lung Cancer Version 3.2022 [Internet]. 2022.

4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Kidney Cancer Version 2.2023 [Internet]. 2022.

5. Definitive stereotactic body radiotherapy (SBRT) for Extracranial Oligometastases;Lewis;Am J Clin Oncol Cancer Clin Trials,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO);Clinical & Experimental Metastasis;2024-08-01